Prenatal treatment of congenital adrenal hyperplasia: A promising experimental therapy of unproven safety

Trends in Endocrinology and Metabolism

Volumn 9, Issue 7, 1998, Pages 290-293

  Miller, Walter L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL ADRENAL HYPERPLASIA; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FETUS; FETUS DEVELOPMENT; HUMAN; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0032171282     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00068-X     Document Type: Article

References (42)

1. Allen JP, Greer MA, McGilvra R, Castro A, Fisher DA Endocrine function in an anencephalic infant. J Clin Endocrinol Metab. 38:1974;94-98.
2. Arai K, Kuwabara Y, Okinaga S The effect of adrenocorticotropic hormone and dexamethasone, administered to the fetus in utero, upon maternal and fetal estrogens. Am J Obstet Gynecol. 113:1972;316-322.
3. Barker DJP, Gluckman PD, Godfrey KMet al. Fetal nutrition and cardiovascular disease in adult life. Lancet. 341:1993;938-941.
4. Benediktsson R, Lindsay R, Noble J, Seckl JR, Edwards CRW Glucocorticoid exposure in utero: a new model for adult hypertension. Lancet. 341:1993;339-341.
5. Benirschke K Adrenals in anencephaly and hydrocephaly. Obstet Gynecol. 8:1956;412-425.
6. 356→Trp causes steroid 21-hydroxylase deficiency. J Biol Chem. 256:1990;3549-3552.
7. David M, Forest MG Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr. 105:1984;799-803.
8. Dittmann RW, Kappes ME, Kappes MH Sexual behavior in adolsecent and adult females with congenital adrenal hyperplasia. Psychoneuroendorinology. 17:1992;153-170.
9. Forest MG, Bétuel H, David M Prenatal treatment in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: update 88 of the French multicentric study. Endocr Res. 15:1989;277-301.
10. Forest MG, David M, Morel Y Prental diagnosis and treatment of 21-hydroxylase deficiency. J Steroid Biochem Mol Biol. 45:1993;75-82.
11. Gray ES, Abramovitch DR Morphologic features of the anencephalic adrenal gland in early pregnancy. Am J Obstet Gynecol. 137:1980;491-495.
12. Haan EA, Sergeantson SW, Norman Ret al. Prenatal diagnosis and successful intrauterine treatment of a female fetus with 21-hydroxylase deficiency. Med J Aust. 156:1992;132-135.
13. Helmburg A, Tusie-Luna M, Tabarelli M, Kofler R, White PC R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversion. Mol Endocrinol. 6:1992;1318-1322.
14. Higashi Y, Tanae A, Inoue H, Fujii-Kuriyama Y Evidence for frequent gene conversions in the steroid 21-hydroxylase (P-450c21) gene: implications for steroid 21-hydroxylase deficiency. Am J Hum Genet. 42:1988;17-25.
15. Kari MA, Raivio KO, Stenman U-H, Voutilainen R Serum cortisol, dehydroepiandrosterone sulfate, and sterol-binding globulins in preterm neonates: effects of gestational age and dexamethasone therapy. Pediatr Res. 40:1996;319-324.
16. Kuhnle U, Bollinger M, Schwarz HP, Knorr D Partnership and sexuality in adult female patients with congenital adrenal hyperplasia. First results of a cross-sectional quality-of-life evaluation. J Steroid Biochem Mol Biol. 45:1993;123-126.
17. Levine RS, Hennekens CH, Jesse MJ Blood pressure in prospective population based cohort of newborn and infant twins. Br Med. J 308:1994;298-302.
18. Matteson KJ, Phillips JA III, Miller WLet al. P450XXI (steroid 21-hydroxylase) gene deletions are not found in family studies of congenital adrenal hyperplasia. Proc Natl Acad Sci USA. 84:1987;5858-5862.
19. Mercado AB, Wilson RC, Cheng KC, Wei JQ, New MI Prenatal treatment and diagnosis of congential adrenal hyperlasia owing to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 80:1995;2014-2020.
20. Meyer-Bahlburg HFL, Gruen RS, New MIet al. Gender change from female to male in classical congenital adrenal hyperplasia. Horm Behavior. 30:1996;319-332.
21. Migeon CJ Comments about the need for prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metal. 70:1990;836-837.
22. Miller WL Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 78:1994;241-246.
23. Miller WL, Morel Y Molecular genetics of 21-hydroxylase deficiency. Annu Rev Genet. 23:1989;371-393.
24. Miyakawa I, Ikeda I, Maeyama M Transport of ACTH across human placenta. J Clin Endocrinol Metab. 39:1974;440-442.
25. Morel Y, Miller WL Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet. 20:1991;1-68.
26. Morel Y, Andre J, Uring-Lambert Bet al. Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia. J Clin Invest. 83:1989;527-536.
27. Mulaikal RM, Migeon CJ, Rock JA Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. New Engl J Med. 316:1987;178-182.
28. Osamura RY Functional prenatal development of anencephalic and normal anterior pituitary glands. Acta Pathol Jpn. 27:1977;495-509.
29. Pang SY, Clark A Newborn screening, prenatal diagnosis, and prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Trends Endocrinol Metab. 1:1990;300-307.
30. Pang S, Clark AT, Freeman LCet al. Maternal side-effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia. J Clin Endocrinol Metab. 75:1992;249-253.
31. Rhoades GG, Jackson LG, Schlesselman SEet al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. New Engl J Med. 320:1989;609-617.
32. Seckl JR, Miller WL How safe is long-term prenatal glucocorticoid treatment? J Am Med Assoc. 277:1997;1077-1079.
33. Speiser PW, New MI Prenatal diagnosis and management of congenital adrenal hyperplasia. Clin Perinatol. 21:1994;631-645.
34. Speiser PW, Dupont J, Zhu Det al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest. 90:1992;584-595.
35. Tapanainen J, Kellokumpu-Lehtinen P, Pelliniemi L, Huhtaniemi I Age-related changes in endogenous steroids of human fetal testis during early and midpregnancy. J Clin Endocrinol Metab. 52:1981;98-102.
36. Trautman PD, Meyer-Bahlburg HFL, Postelnek J, New MI Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology. 20:1995;439-449.
37. Tusie-Luna MT, Traktman P, White PC Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J Biol Chem. 265:1990;20916-20922.
38. Wedell A, Thilén A, Ritzén EM, Stengler B, Luthman H Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab. 78:1994;1145-1152.
39. Whincup PH, Cook D, Papacosta O, Walker M Birth weight and blood pressure: cross-sectional and longitudinal relations in childhood. Br Med. J 311:1995;773-776.
40. White PC, Vitek B, Dupont B, New MI Characterization of frequent deletions causing steorid 21-hydroxylase deficiency. Proc Natl Acad Sci USA. 85:1988;4436.
41. White PC, Mune T, Agarwal AK 11β-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev. 18:1997;135-156.
42. Zucker KJ, Bradley SJ, Oliver Get al. Psychosexual development of women with congenital adrenal hyperplasia. Horm Behavior. 30:1996;300-318.